Both TAZ and IHH are increased in human livers with NASH but not with simple steatosis [69,91], suggesting that hepatocyte TAZ could play a role in promoting NAFLD disease progression, i.e., the transition from steatosis to NASH. This evidence concerns the gene WWTR1 and metabolic dysfunction-associated steatotic liver disease.